A combined analysis of double‐blind trials of the efficacy and tolerability of doxazosin‐gastrointestinal therapeutic system, doxazosin standard and placebo in patients with benign prostatic hyperplasia

Roger S. Kirby,M. Andersen,P. Gratzke,Christer Dahlstrand,K. Hoye
DOI: https://doi.org/10.1046/j.1464-410x.2001.02032.x
2001-02-01
BJU International
Abstract:Objective To report an integrated analysis of two previous studies fully characterizing the clinical utility of the controlled‐release gastrointestinal therapeutic system (GITS) formulation of doxazosin in the treatment of benign prostatic hyperplasia (BPH).
What problem does this paper attempt to address?